Here are 4 biotech stocks that could get a boost from Trump’s new regulatory climate
Read more at MarketWatch
-
Could prison companies get a boost from Trump's immigration policies?
Top stories - CBS News - November 7 -
This REIT could get a boost from a box-office rebound at AMC
Business - MarketWatch - Yesterday -
Bank stocks soar as Trump victory expected to lead to looser regulatory backdrop
Business - MarketWatch - November 6 -
This biotech’s stock could double if its treatment for major depressive disorder succeeds, says Mizuho
Business - MarketWatch - November 14 -
Caregivers’ retirement security — often jeopardized by time away from work — could get a boost from these proposals
Business - MarketWatch - 4 days ago -
Here’s why JPMorgan’s stock gets one analyst’s only downgrade after the Trump bank-stock rally
Business - MarketWatch - 3 days ago -
These stocks could benefit from Trump’s election victory, B. Riley says
Business - MarketWatch - November 6 -
TikTok's 'Winter Arc’ challenge helps you get ahead of your New Year goals. Here’s why it’s gone viral and 4 tips to get started
Business - CNBC - November 15 -
M&A should get a boost from Trump’s election — but most deals are doomed to fail
Business - MarketWatch - 36 minutes ago
More from MarketWatch
-
8 ways almost anyone can create a happier retirement
Business - MarketWatch - 30 minutes ago -
M&A should get a boost from Trump’s election — but most deals are doomed to fail
Business - MarketWatch - 36 minutes ago -
The comedic actor Danny McBride’s latest role? Tequila entrepreneur.
Business - MarketWatch - 48 minutes ago -
Investors can look ahead to Nvidia, Treasury bonds and a bullish finish to 2024
Business - MarketWatch - 1 hour ago -
This Roth strategy lets elite savers stash $70,000 in their 401(k) in 2025
Business - MarketWatch - 1 hour ago